Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04926090 · ClinicalTrials.gov registry record · NA

Developing Mental Health Supports for Autistic Students

A NA study of Autism Spectrum Disorder and Depression, Anxiety, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT04926090 is a NA study of Autism Spectrum Disorder and Depression, Anxiety that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 19 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04926090, a NA study of Autism Spectrum Disorder and Depression, Anxiety, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The present study aims to expand the availability of emotional supports in order to promote successful transitions and longer-term outcomes for autistic students in PSE.

Interventions

  • BEHAVIORAL Emotional Support Plan - Clinician Guided (ESP-C)
  • BEHAVIORAL Emotional Support Plan - Self Guided (ESP-S)

Study Locations (1)

New Jersey

  • Rutgers University - Piscataway

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2021-07-26
Est. Completion 2022-07-27
Phase NA

What the Registry Record Tells You About NCT04926090

The ClinicalTrials.gov registry entry for NCT04926090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (86% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Emotional Support Plan - Clinician Guided (ESP-C) is the first listed.

NCT04926090 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04926090 about?

NCT04926090 is a clinical study titled "Developing Mental Health Supports for Autistic Students". The present study aims to expand the availability of emotional supports in order to promote successful transitions and longer-term outcomes for autistic students in PSE.

What is the current status of trial NCT04926090?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-07-26. Estimated completion is 2022-07-27.

What conditions does trial NCT04926090 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Depression, Anxiety.

What interventions are being tested in trial NCT04926090?

The interventions under investigation include: Emotional Support Plan - Clinician Guided (ESP-C) (BEHAVIORAL), Emotional Support Plan - Self Guided (ESP-S) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04926090?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04926090 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.